Tomimpong, Edralyn .
HRN: 20-14-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2023
CO-AMOXICLAV 625MG (TAB)
07/05/2023
07/12/2023
ORAL
625
BID
Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes